Clinical Trials Directory

Trials / Completed

CompletedNCT00815126

Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity

Association Between Nasal Provocation Test With Lysine-Acetylsalicylate(ASA) and Clinical Diagnosis in Patients With Aspirin/Nonsteroidal Anti-Inflammatory Drugs(NSAIDs) and/or Acetaminophen Immediate Sensitivity Reactions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
15 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study aims to compare the efficacy of nasal provocation test with Lysine-Acetylsalicylate in patients with history of NSAIDs hypersensitivity between mucocutaneous symptoms and respiratory symptoms and laboratory outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDURELysine-ASA Nasal ProvocationTestLysine-ASA 80 µl (16 mg of aspirin) will be installed in both nostrils with pipette

Timeline

Start date
2008-11-01
Primary completion
2009-03-01
Completion
2009-04-01
First posted
2008-12-29
Last updated
2010-11-18

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT00815126. Inclusion in this directory is not an endorsement.

Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (NCT00815126) · Clinical Trials Directory